Navigation Links
ChemGenex Reports Successful Personalized Dosing of Quinamed at,ASCO

repeated). Using these dosing regimens, 64% of rapid and intermediate acetylators and 77% of slow acetylators showed no dose-limiting drug toxicities or dose-delay/holds during treatment.

-- In a population of heavily pretreated patients who were refractory to multiple existing therapies and who had advanced tumors, there was evidence of antitumor activity in a range of tumor types. Three prostate cancers showed a decline in prostate specific antigen (PSA), with one of these achieving a partial response. Two patients with ovarian cancer achieved stable disease accompanied by a decline in the ovarian cancer biomarker CA125. One patient with gastrointestinal stromal tumor (GIST) demonstrated stable disease which was sustained over 18 monthly cycles of amonafide.

Greg Collier, Ph.D., Chief Executive Officer and Managing Director of ChemGenex said that the results were a significant step in the development of personalized medicines. "The data that Dr Kuhn presented today show very clearly that we now understand the effect of genotype on amonafide metabolism, and that we can dose patients to minimize the side effects of therapy. We are encouraged by the signs of anticancer activity across a range of tumor types in patients who had failed multiple prior therapies, and look forward to progressing Quinamed into further development for indications where the clinical need and commercial potential is greatest."

Quinamed(R) is a registered trademark of ChemGenex Pharmaceuticals Limited.

About ChemGenex Pharmaceuticals Limited (www.chemgenex.com)

ChemGenex Pharmaceuticals is a pharmaceutical development company dedicated to improving the lives of patients by developing therapeutics in the areas of oncology, diabetes and obesity. ChemGenex harnesses the power of genomics for target discovery and validation, and in clinical trials to develop more individualized therapeutic outcomes. ChemGenex's lead compound, Ceflatonin(R), is currently in phase
'"/>




Page: 1 2 3 4

Related medicine technology :

1. ChemGenex Reports Successful Personalized Dosing of Quinamed at ASCO
2. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
3. Independent Publication Confirms Growing Therapeutic Challenge of T315I Mutation in Patients with CML, Notes ChemGenex
4. Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
5. Cobalis Reports Phase III Trial Results for PreHistin in Seasonal Allergic Rhinitis
6. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
7. Cytos Biotechnology Reports Results from Phase IIa Study with CYT003-QbG10 in Patients Suffering from Atopic Dermatitis
8. Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
9. The European Myeloma Platform Reports New Survival data for Revlimid Presented at the International Myeloma Workshop in Greece
10. Cytochroma Reports Positive Phase I Clinical Data for CTA018 Injection
11. Speedel Reports Successful SPP635 Phase IIa Trial in Hypertension
Post Your Comments:
(Date:8/29/2014)... /PRNewswire-iReach/ -- Market Research Report on Global and ... professional and in-depth market survey on Global ... report firstly reviews the basic information of X-Ray ... technology. The report then explores global and China,s ... product specification, capacity, Production value, and market share ...
(Date:8/29/2014)... , Aug. 29, 2014 Pomerantz LLP ... S.A. ("EDAP" or the "Company") (NASDAQ: EDAP ) ... in United States District Court, Southern District of ... is on behalf of a class consisting of all ... 1, 2013 and July 30, 2014, inclusive (the "Class ...
(Date:8/29/2014)... Aug. 29, 2014  BC Technical, the nation,s leading ... Medical Imaging, a leader in sales, service and installation ... allows BC Technical to continue to expand their resources ... and CT modalities. "We are committed ... Mark Alvarez , president and CEO of BC Technical. ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against EDAP TMS S.A. and Certain Officers - EDAP 3BC Technical Acquires Polaris Medical Imaging 2
... , , , MELBOURNE, Australia, Dec. ... New Objective , Key points: , *Single injection of ... levels and sustained reduction in blood glucose levels , ... of pancreatic islets, and increase in insulin-producing beta cells ...
... , SANDWICH, Mass., Dec. 17 ... is too much and how do those working with patients ... from over exposure? Veteran-owned RADeCO Health, Inc. of Sandwich, Ma. ... CT dosimeter, a new monitoring device designed to monitor ionizing ...
Cached Medicine Technology:Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes 2Single Dose of Proprietary Adult Stem Cells Regenerates Damaged Pancreas and Reduces Blood Glucose Levels in Diabetes 3Revolutionary Radiation Monitoring Device for CT Scans 2Revolutionary Radiation Monitoring Device for CT Scans 3
(Date:8/30/2014)... 30, 2014 "My niece developed a ... at any moment, her fever might get worse," said ... me well aware of how she was doing, I ... ALARM to continuously monitor a child's temperature. The unit ... This ensures that prompt medical care can be given, ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The ... mesh lawsuits ( http://www.injurybeacon.com/transvaginal-mesh/ ) filed against Boston ... sever four cases selected for one of the ... on August 18, 2014, U.S. District Judge Joseph ... Virginia disagrees with Boston Scientific’s contention that a ...
(Date:8/30/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 Top10BestSEOHosting.com ... experienced researchers have announced that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ... the current market. Also, they has announced that ... webmasters. , Hostgator, one of the Top ... supplier of cheap Windows hosting, and it offers ...
(Date:8/30/2014)... August 28th, 2014: With the prevalence ... and the toll that takes on the individual as ... education for physical therapists addresses this problem. , In ... others, Hands-On Seminars is offering discounts on their continuing ... styles are available to fit the individual needs of ...
Breaking Medicine News(10 mins):Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuit News: Federal Judge Refuses Boston Scientific Request for Separate Trials in Four Bellwether Cases, Bernstein Liebhard LLP Reports 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Leader in Manual Therapy Continuing Education Makes it Easier for Physical Therapists to Improve Results on Patients 2
... long-term outcomes, researchers say , THURSDAY, Oct. 25 (HealthDay News) ... peptide (ANP) can lessen cardiac injuries after heart attack and ... a Japanese study in this week,s issue of The ... damaged heart muscle (infarct) and lessened what,s known as "reperfusion ...
... PALO ALTO, Calif., Oct. 26 Varian Medical,Systems, ... in the industry in overall,service performance by the ... by IMV, Ltd., a research company that,analyzes service ... performance on the basis of telephone interviews with,customers. ...
... respected radiology groups partners ... IT solutions, BOSTON, Oct. 26 AMICAS, Inc. ... image and information management,solutions, today announced that it has ... AZ. (Logo: http://www.newscom.com/cgi-bin/prnh/20060202/AMICASLOGO ) "AMICAS ...
... Strengthen International ... Growth Opportunities, MONROVIA, Calif, Oct. ... manufacturer and marketer of,minimally invasive ophthalmic products, today announced that it ... shareholders in,Canon Staar Co., Inc., a joint venture that was formed ...
... Third ... Straight Year, FLINT, Mich., Oct. 26 ... Medicaid health,plans have been recognized by U.S. News & World Report as ... top 50,Commercial plans and the top 25 plans for both Medicare and ...
... and Support for "Patient Navigator,Program" Site At ... EVERETT, Wash., Oct. 25 The American Cancer,Society ... Program at,the Providence Regional Cancer Partnership in Everett, ... a strategic nationwide effort to,significantly extend the reach ...
Cached Medicine News:Health News:Varian Medical Systems Ranks First in Overall Service Performance in 2007 Survey of U.S. Radiation Oncology Professionals 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 3Health News:STAAR Surgical to Purchase Canon's Interest in Japanese Joint Venture 2Health News:STAAR Surgical to Purchase Canon's Interest in Japanese Joint Venture 3Health News:STAAR Surgical to Purchase Canon's Interest in Japanese Joint Venture 4Health News:STAAR Surgical to Purchase Canon's Interest in Japanese Joint Venture 5Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 2Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 3Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 4Health News:Everett-Area Cancer Patients Can More Easily Navigate Health Care System Thanks to the American Cancer Society and AstraZeneca 5
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
The Optima III line of laparoscopic hand instruments provides a well-crafted set of instruments designed for strength and durability....
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
For use with Snap-In Snap-Out-II tip inserts. Available in five styles, the Snap-In Snap-Out-II Laparoscopic Instrument Handles offer the broadest range available....
Medicine Products: